- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Diabetes Injection Pens market will register a 4.3% CAGR in terms of revenue, the global market size will reach $ 4904.1 million by 2025, from $ 4151.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Diabetes Injection Pens business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Injection Pens market by type, application, key manufacturers and key regions and countries.
This study considers the Diabetes Injection Pens value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Reusable Insulin Pens
Disposable Insulin Pens
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital & Clinic
Retail Pharmacy
Online Sales
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novo Nordisk
Eli Lilly
BD
Ypsomed Holding
Sanofi
Ganlee
Dongbao
Delfu
Owen Mumford
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Diabetes Injection Pens consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Diabetes Injection Pens market by identifying its various subsegments.
Focuses on the key global Diabetes Injection Pens manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diabetes Injection Pens with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Diabetes Injection Pens submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diabetes Injection Pens Consumption 2015-2025
2.1.2 Diabetes Injection Pens Consumption CAGR by Region
2.2 Diabetes Injection Pens Segment by Type
2.2.1 Reusable Insulin Pens
2.2.2 Disposable Insulin Pens
2.3 Diabetes Injection Pens Consumption by Type
2.3.1 Global Diabetes Injection Pens Consumption Market Share by Type (2015-2020)
2.3.2 Global Diabetes Injection Pens Revenue and Market Share by Type (2015-2020)
2.3.3 Global Diabetes Injection Pens Sale Price by Type (2015-2020)
2.4 Diabetes Injection Pens Segment by Application
2.4.1 Hospital & Clinic
2.4.2 Retail Pharmacy
2.4.3 Online Sales
2.5 Diabetes Injection Pens Consumption by Application
2.5.1 Global Diabetes Injection Pens Consumption Market Share by Type (2015-2020)
2.5.2 Global Diabetes Injection Pens Value and Market Share by Type (2015-2020)
2.5.3 Global Diabetes Injection Pens Sale Price by Type (2015-2020)
3 Global Diabetes Injection Pens by Company
3.1 Global Diabetes Injection Pens Sales Market Share by Company
3.1.1 Global Diabetes Injection Pens Sales by Company (2018-2020)
3.1.2 Global Diabetes Injection Pens Sales Market Share by Company (2018-2020)
3.2 Global Diabetes Injection Pens Revenue Market Share by Company
3.2.1 Global Diabetes Injection Pens Revenue by Company (2018-2020)
3.2.2 Global Diabetes Injection Pens Revenue Market Share by Company (2018-2020)
3.3 Global Diabetes Injection Pens Sale Price by Company
3.4 Global Diabetes Injection Pens Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Diabetes Injection Pens Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Diabetes Injection Pens Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Diabetes Injection Pens by Regions
4.1 Diabetes Injection Pens by Regions
4.2 Americas Diabetes Injection Pens Consumption Growth
4.3 APAC Diabetes Injection Pens Consumption Growth
4.4 Europe Diabetes Injection Pens Consumption Growth
4.5 Middle East & Africa Diabetes Injection Pens Consumption Growth
5 Americas
5.1 Americas Diabetes Injection Pens Consumption by Countries
5.1.1 Americas Diabetes Injection Pens Consumption by Countries (2015-2020)
5.1.2 Americas Diabetes Injection Pens Value by Countries (2015-2020)
5.2 Americas Diabetes Injection Pens Consumption by Type
5.3 Americas Diabetes Injection Pens Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Diabetes Injection Pens Consumption by Regions
6.1.1 APAC Diabetes Injection Pens Consumption by Regions (2015-2020)
6.1.2 APAC Diabetes Injection Pens Value by Regions (2015-2020)
6.2 APAC Diabetes Injection Pens Consumption by Type
6.3 APAC Diabetes Injection Pens Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Diabetes Injection Pens by Countries
7.1.1 Europe Diabetes Injection Pens Consumption by Countries (2015-2020)
7.1.2 Europe Diabetes Injection Pens Value by Countries (2015-2020)
7.2 Europe Diabetes Injection Pens Consumption by Type
7.3 Europe Diabetes Injection Pens Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Diabetes Injection Pens by Countries
8.1.1 Middle East & Africa Diabetes Injection Pens Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Diabetes Injection Pens Value by Countries (2015-2020)
8.2 Middle East & Africa Diabetes Injection Pens Consumption by Type
8.3 Middle East & Africa Diabetes Injection Pens Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Diabetes Injection Pens Distributors
10.3 Diabetes Injection Pens Customer
11 Global Diabetes Injection Pens Market Forecast
11.1 Global Diabetes Injection Pens Consumption Forecast (2021-2025)
11.2 Global Diabetes Injection Pens Forecast by Regions
11.2.1 Global Diabetes Injection Pens Forecast by Regions (2021-2025)
11.2.2 Global Diabetes Injection Pens Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Diabetes Injection Pens Forecast by Type
11.8 Global Diabetes Injection Pens Forecast by Application
12 Key Players Analysis
12.1 Novo Nordisk
12.1.1 Company Information
12.1.2 Diabetes Injection Pens Product Offered
12.1.3 Novo Nordisk Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Novo Nordisk Latest Developments
12.2 Eli Lilly
12.2.1 Company Information
12.2.2 Diabetes Injection Pens Product Offered
12.2.3 Eli Lilly Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Eli Lilly Latest Developments
12.3 BD
12.3.1 Company Information
12.3.2 Diabetes Injection Pens Product Offered
12.3.3 BD Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 BD Latest Developments
12.4 Ypsomed Holding
12.4.1 Company Information
12.4.2 Diabetes Injection Pens Product Offered
12.4.3 Ypsomed Holding Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Ypsomed Holding Latest Developments
12.5 Sanofi
12.5.1 Company Information
12.5.2 Diabetes Injection Pens Product Offered
12.5.3 Sanofi Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Sanofi Latest Developments
12.6 Ganlee
12.6.1 Company Information
12.6.2 Diabetes Injection Pens Product Offered
12.6.3 Ganlee Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Ganlee Latest Developments
12.7 Dongbao
12.7.1 Company Information
12.7.2 Diabetes Injection Pens Product Offered
12.7.3 Dongbao Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Dongbao Latest Developments
12.8 Delfu
12.8.1 Company Information
12.8.2 Diabetes Injection Pens Product Offered
12.8.3 Delfu Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Delfu Latest Developments
12.9 Owen Mumford
12.9.1 Company Information
12.9.2 Diabetes Injection Pens Product Offered
12.9.3 Owen Mumford Diabetes Injection Pens Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Owen Mumford Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Diabetes Injection Pens Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Player
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
